BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2019
View Archived Issues
CRISPR: Efficient editing and efficient inhibition
Read More
Gilead and Goldfinch Bio enter strategic collaboration to develop novel therapies for kidney disease
Read More
Imidazopyridines targeting methionyl-tRNA synthetase for the treatment of Cryptosporidium infection
Read More
Phase II results on ribaxamase to prevent C. difficile infection in beta-lactam-treated patients
Read More
New mouse model identifies MYC role in the tumorigenesis of group 3 medulloblastoma
Read More
First patient treated in phase I study MCLA-145 for the treatment of advanced solid tumors
Read More
Dosing begins in phase IIa PANASH study of liver stem cell therapy in late-stage NASH
Read More
CheckMate498 phase III study of Opdivo does not meet primary endpoint
Read More
resTORbio initiates phase III program of RTB-101 in clinically symptomatic respiratory illness
Read More
Nintedanib ophthalmic nanosuspension tested in animal model as pterygium treatment
Read More
First clinical results on K-0706 presented as potential treatment for Parkinson's disease
Read More
CAR T-cell therapy targeting AMHR2, a potential treatment for ovarian cancer
Read More
Bristol-Myers Squibb presents new hSTING agonists
Read More
Incyte patents PI3Kgamma inhibitors
Read More
Epizyme discloses EHMT1 and/or EHMT2 inhibitors
Read More
eFFECTOR Therapeutics describes MNK1 and MNK2 inhibitors
Read More
Tempest Therapeutics divulges IDO1 inhibitors
Read More
New phase I trial explores Precigen's PRGN-3005 UltraCAR-T cells for advanced ovarian cancer
Read More
Aptose begins phase Ia/Ib study of CG-806 in CLL, SLL and NHL
Read More
Mustang announces new phase I trial of CAR T-cell therapy for multiple myeloma
Read More
BioCryst completes phase I study of intravenous galidesivir in healthy subjects
Read More
Pooled safety analyses of global roxadustat phase III program confirm CV safety
Read More
Liver chats with fat via serum protein GPNMB
Read More
Urinary NT-proBNP a pulmonary hypertension marker in preterm infants with bronchopulmonary dysplasia
Read More
